Interpace Biosciences
Why Robinhood?
You can watch IDXG and buy or sell other stocks, ETFs, and their options commission-free!About IDXG
Interpace Biosciences, Inc. operates as an bioinformatics company, which engages in the development and commercialization of molecular diagnostic test and pathology services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment; ThyGenX and PathFinderTG which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay.
IDXG Key Statistics
Stock Snapshot
As of today, Interpace Biosciences(IDXG) shares are valued at $1.46. The company's market cap stands at 55.77M, with a P/E ratio of 0.00 and a dividend yield of 0.00%.
On 2026-07-25, Interpace Biosciences(IDXG) stock traded between a low of $1.44 and a high of $1.46. Shares are currently priced at $1.46, which is +1.3% above the low and 0.0% below the high.
Interpace Biosciences(IDXG) shares are trading with a volume of 400, against a daily average of 573.44K.
In the last year, Interpace Biosciences(IDXG) shares hit a 52-week high of $1.46 and a 52-week low of $0.38.
In the last year, Interpace Biosciences(IDXG) shares hit a 52-week high of $1.46 and a 52-week low of $0.38.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.